{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:58:10Z","timestamp":1791496690505,"version":"4.3.4"},"reference-count":16,"publisher":"Wiley","issue":"11-12","license":[{"start":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:00:00Z","timestamp":1667174400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["analyticalsciencejournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Drug Testing and Analysis"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Doping analysis with a fast\u2010turnaround\u2010time reporting of 24\/48\u2009h is a \u201ctraditional\u201d requirement for major competitions such as the Olympic Games, which require tremendously increased allocation of resources, especially during the COVID\u201019 pandemic. The \u201cClosed\u2010Loop\u201d concept and operation mode established by the Beijing Organizing Committee for the 2022 Olympic and Paralympic Winter Games (BOCOG) provided a relatively isolated environment to non\u2010Games\u2010related civilians. To maintain this system, more than 200 persons were included as supporting crew of the laboratory with massive logistic resources allocated. The National Anti\u2010Doping Laboratory in Beijing carried out the analysis mission of the Beijing 2022 Olympic and Paralympic Winter Games. During the Winter Olympics, 3165 samples were analyzed, whereas during the Paralympics, 679 samples were analyzed. The workforce accomplishing this work was composed of 36 domestic analysts, 20 international experts from other World Anti\u2010Doping Agency\u2010accredited laboratories, 61 university students with suitable majors, and 12 on\u2010site instrumental engineers. This article summarizes the achievements from the laboratory's preparation phase; in\u2010Game operational details such as instruments, methods, workforces, and facility; and the Quality Assurance measures to maintain the integrity and correctness of results reported to the Result Management Authority, with the effect of the pandemic and \u201cClosed\u2010Loop\u201d situation during the whole process highlighted.<\/jats:p>","DOI":"10.1002\/dta.3384","type":"journal-article","created":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T03:56:10Z","timestamp":1667188570000},"page":"1853-1863","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Operation of the anti\u2010doping laboratory for the Beijing 2022 Olympic and Paralympic Winter Games"],"prefix":"10.1002","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7359-9259","authenticated-orcid":false,"given":"Yunfei","family":"Wang","sequence":"first","affiliation":[{"name":"National Anti\u2010Doping Laboratory Beijing Sport University  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisi","family":"Zhang","sequence":"additional","affiliation":[{"name":"National Anti\u2010Doping Laboratory Beijing Sport University  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyi","family":"Xing","sequence":"additional","affiliation":[{"name":"National Anti\u2010Doping Laboratory Beijing Sport University  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,10,31]]},"reference":[{"key":"e_1_2_17_2_1","unstructured":"WADA.International standard for laboratories (ISL).2021. Accessed January 1 2021.https:\/\/www.wada-ama.org\/sites\/default\/files\/resources\/files\/isl_2021.pdf"},{"key":"e_1_2_17_3_1","unstructured":"IOC.Anti\u2010doping rules applicable to the XXIV Olympic Winter Games Beijing 2022. Accessed November 1 2021.https:\/\/stillmed.olympics.com\/media\/Documents\/Athletes\/Fight-Against-Doping\/Beijing-2022\/AAnt-Doping-Rules-applicable-Beijing-2022.pdf"},{"key":"e_1_2_17_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/dta.1734"},{"key":"e_1_2_17_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/dta.2329"},{"key":"e_1_2_17_6_1","unstructured":"IOC.Beijing 2022 playbook. Accessed December 1 2021.https:\/\/stillmed.olympics.com\/media\/Documents\/Olympic-Games\/Beijing-2022\/Playbooks\/The-Playbook-RHBs-IFs-TOP-OF-PF-Press-Workforce-December-2021.pdf#_ga=2.21712755.936922105.1658816007-925739777.1658816007"},{"key":"e_1_2_17_7_1","first-page":"30","article-title":"Application of dried blood spot sampling equipment and method in doping control","volume":"41","author":"Wen HT","year":"2021","journal-title":"Chin Sport Sci"},{"key":"e_1_2_17_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/dta.1915"},{"key":"e_1_2_17_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/dta.3200"},{"key":"e_1_2_17_10_1","unstructured":"WADA.Analysis reporting & management of urinary human chorionic gonadotrophin (hCG) and luteinizing hormone (LH) findings in male athletes. Accessed April 1 2021.https:\/\/www.wada-ama.org\/sites\/default\/files\/2022-01\/td2021cg-lh_final_eng_0.pdf"},{"key":"e_1_2_17_11_1","unstructured":"WADA.Human growth hormone (hGH) isoform differential immunoassays for doping control analyses. Accessed April 1 2021.https:\/\/www.wada-ama.org\/sites\/default\/files\/2022-01\/td2021gh_final_eng_0.pdf"},{"key":"e_1_2_17_12_1","unstructured":"WADA.Laboratory guidelines\u2014human growth hormone (hGH) biomarkers test. Accessed January 29 2021.https:\/\/www.wada-ama.org\/sites\/default\/files\/resources\/files\/wada_guidelines_hgh_biomarkers_test_v3_jan_2021_eng.pdf"},{"key":"e_1_2_17_13_1","unstructured":"WADA.Analytical requirements for the hematological module of the athlete biological passport. Accessed June 1 2021.https:\/\/www.wada-ama.org\/sites\/default\/files\/resources\/files\/td2021bar_final_eng_v2.0.pdf"},{"key":"e_1_2_17_14_1","unstructured":"WADA.Laboratory guidelines\u2014gene doping detection based on polymerase chain reaction (PCR). Accessed January 29 2021.https:\/\/www.wada-ama.org\/sites\/default\/files\/resources\/files\/wada_guidelines_for_gene_doping_pcr_test_v1_jan_2021_eng.pdf"},{"key":"e_1_2_17_15_1","unstructured":"WADA.Decision limits for the confirmatory quantification of exogenous threshold substances by chromatography\u2010based analytical methods. Accessed January 1 2022.https:\/\/www.wada-ama.org\/sites\/default\/files\/2022-01\/td2022dl_v1.0_final_eng_0.pdf"},{"key":"e_1_2_17_16_1","unstructured":"WADA.Laboratory guidelines\u2014TUE enquiries by accredited laboratories. Accessed January 29 2021.https:\/\/www.wada-ama.org\/sites\/default\/files\/resources\/files\/wada_guidelines_for_tue_enquiries_v4_jan_2021_eng.pdf"},{"key":"e_1_2_17_17_1","unstructured":"WADA.Report of the independent observers\u2014Olympic Winter Games Beijing 2022. Accessed July 14 2022.https:\/\/www.wada-ama.org\/sites\/default\/files\/2022-07\/2022_beijing_io_report_olympic_winter_games_final_en.pdf"}],"container-title":["Drug Testing and Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/dta.3384","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/dta.3384","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/dta.3384","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T22:34:52Z","timestamp":1760394892000},"score":1,"resource":{"primary":{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/10.1002\/dta.3384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,31]]},"references-count":16,"journal-issue":{"issue":"11-12","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["10.1002\/dta.3384"],"URL":"https:\/\/doi.org\/10.1002\/dta.3384","archive":["Portico"],"relation":{},"ISSN":["1942-7603","1942-7611"],"issn-type":[{"value":"1942-7603","type":"print"},{"value":"1942-7611","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,31]]},"assertion":[{"value":"2022-07-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}